Dharmaj Crop Guard Limited, one of the fastest-growing agrochemicals companies, has announced Q3 FY25 revenue of Rs. 174.5 crore, a growth of 41% YoY whereas profit was Rs. 1.2 crore, down by 85%. 

Commenting on the results, Rameshbhai Talavia, Chairman and Managing Director said, “Dharmaj has demonstrated robust growth momentum in Q3 FY25, with a 41% YoY increase in revenue from operations. This growth is primarily driven by strong performance in Branded and Institutional Formulations verticals, further bolstered by the Active Ingredients segment, which has emerged as a new growth engine for the company. 9MFY25 revenue from operations stands higher by 38% YoY."

"The Rabbi season has started on a positive note, aligning with earlier expectations due to good rainfall and higher water reservoir levels across the country. Growth in formulation verticals continues to be volume-driven, despite lower realizations compared to the previous financial year, with no significant fluctuations in product prices observed after the moderation in September-October," commented Talavia.

"In the Branded Formulations segment, initial response from new markets such as South India has been encouraging, suggesting good growth in these markets in the coming financial year. However, certain markets like Rajasthan and Uttar Pradesh have underperformed our expectations, leading to a reevaluation of team and strategy in these regions," said Talavia.

"Export performance remains muted due to political and social unrest in Bangladesh, a key export market, and moderation in one particular product for some African markets. However, the company expects improvement as the Bangladesh market reopens after a six-month halt, and plans are in place to enter new markets in the coming financial year with the growing export product registration portfolio," Talavia added.

"The Active Ingredients vertical has shown promising results, achieving a revenue of Rs. 154.8 crore in 9M FY25, in line with our capacity utilization targets for the first year. However, front-loaded expenses in this segment have resulted in a short-term drag on the Profit & Loss statement, including elevated Operating Expenses and higher Depreciation and Finance costs. As the business scales up, these expenses are expected to normalize on a higher revenue base," said Talavia.

"Looking ahead, Dharmaj remains committed to building a pan-India brand presence, scaling up the active ingredients business, and growing exports for both formulations and active ingredients. These strategic initiatives are expected to drive sustained growth and market expansion in the coming year,” added Talavia.